Key motor neurone disease research projects land 36.5m of ... - National Health Executive
| NRO Stock | EUR 44.90 0.05 0.11% |
About 61% of Neurones' investor base is looking to short. The analysis of current outlook of investing in Neurones suggests that many traders are alarmed regarding Neurones' prospects. The current market sentiment, together with Neurones' historical and current headlines, can help investors time the market. In addition, many technical investors use Neurones stock news signals to limit their universe of possible portfolio assets.
Neurones |
Key motor neurone disease research projects land 36.5m of ... National Health Executive
Read at news.google.com
 |
Neurones Fundamental Analysis
We analyze Neurones' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neurones using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neurones based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Neurones is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Neurones Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurones stock to make a market-neutral strategy. Peer analysis of Neurones could also be used in its relative valuation, which is a method of valuing Neurones by comparing valuation metrics with similar companies.
Peers
Neurones Related Equities
| STMN | Straumann Holding | 0.70 | ||||
| ORAP | Orapi SA | 0.62 | ||||
| EWLD | Amundi Index | 0.38 | ||||
| CB3 | Amundi Index | 0.22 | ||||
| MTU | Manitou BF | 0.51 | ||||
| CRI | Chargeurs | 0.91 | ||||
| EKI | Ekinops SA | 1.43 |
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |